EMAIL THIS PAGE TO A FRIEND

Autophagy

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.


PMID 26312386

Abstract

Metastatic renal cell carcinomas (mRCC) are highly vascularized tumors that are a paradigm for the treatment with antiangiogenesis drugs targeting the vascular endothelial growth factor (VEGF) pathway. The available drugs increase the time to progression but are not curative and the patients eventually relapse. In this study we have focused our attention on the molecular mechanisms leading to resistance to sunitinib, the first line treatment of mRCC. Because of the anarchic vascularization of tumors the core of mRCC tumors receives only suboptimal concentrations of the drug. To mimic this in vivo situation, which is encountered in a neoadjuvant setting, we exposed sunitinib-sensitive mRCC cells to concentrations of sunitinib below the concentration of the drug that gives 50% inhibition of cell proliferation (IC50). At these concentrations, sunitinib accumulated in lysosomes, which downregulated the activity of the lysosomal protease CTSB (cathepsin B) and led to incomplete autophagic flux. Amino acid deprivation initiates autophagy enhanced sunitinib resistance through the amplification of autolysosome formation. Sunitinib stimulated the expression of ABCB1 (ATP-binding cassette, sub-family B [MDR/TAP], member 1), which participates in the accumulation of the drug in autolysosomes and favor its cellular efflux. Inhibition of this transporter by elacridar or the permeabilization of lysosome membranes with Leu-Leu-O-methyl (LLOM) resensitized mRCC cells that were resistant to concentrations of sunitinib superior to the IC50. Proteasome inhibitors also induced the death of resistant cells suggesting that the ubiquitin-proteasome system compensates inhibition of autophagy to maintain a cellular homeostasis. Based on our results we propose a new therapeutic approach combining sunitinib with molecules that prevent lysosomal accumulation or inhibit the proteasome.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA002199
Anti-ABCB1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2702025
Anti-ABCB1 antibody produced in rabbit
SAB4500797
Anti-AKT antibody produced in rabbit, affinity isolated antibody
SAB4500799
Anti-AKT antibody produced in rabbit, affinity isolated antibody
SAB4500800
Anti-AKT antibody produced in rabbit, affinity isolated antibody
SAB4500802
Anti-AKT antibody produced in rabbit, affinity isolated antibody
SAB4500803
Anti-AKT antibody produced in rabbit, affinity isolated antibody
SAB4500796
Anti-AKT, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500798
Anti-AKT, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500004
Anti-AKT, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4300335
Anti-AKT1 (Ab-308) antibody produced in rabbit, affinity isolated antibody
SAB4300575
Anti-AKT1 (Ab-450) antibody produced in rabbit, affinity isolated antibody
SAB4300334
Anti-AKT1 (Ab-473) antibody produced in rabbit, affinity isolated antibody
GW22757 Anti-AKT1 (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW22775 Anti-AKT1 (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2501934
Anti-AKT1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3500216
Anti-Akt1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA002891
Anti-AKT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV06008 Anti-AKT1 antibody produced in rabbit, affinity isolated antibody
SAB4500007
Anti-AKT1 antibody produced in rabbit, affinity isolated antibody
AV36578
Anti-ANXA3 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV36579
Anti-ANXA3 (AB2) antibody produced in rabbit, IgG fraction of antiserum
SAB1405458
Anti-ANXA3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA013398
Anti-ANXA3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA013431
Anti-ANXA3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW22667 Anti-ARD1A antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1406650
Anti-ARD1A antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2100142
Anti-ARD1A antibody produced in rabbit, affinity isolated antibody
SAB1411481
Anti-ARD1A antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
GW21443A Anti-EEA1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution